Výsledky vyhledávání - "Alison M. Duarte"

Phase 2 Study of Talabostat and Rituximab in Patients with Advanced Chronic Lymphoctyic Leukemia (CLL) Previously Treated with a Rituximab/Fludarabine Regimen

Autor: Margaret J. Uprichard, Anne Marie Maddox, Susan O'Brien, Jennifer R. Brown, P. Cook, Alison M. Duarte, Khuda Dad Khan, Eric Haltom, Kanti R. Rai

Publikováno v: Blood. 106:2125-2125

Background: Talabostat (T) is an orally available inhibitor of dipeptidyl peptidases (DPP) such as fibroblast activation protein (FAP). FAP is expressed in bone marrow, lymph nodes, and the stroma of solid tumors. T induces the production of cytokine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cc898b0858fa25e426b521d00cbf6e52
https://doi.org/10.1182/blood.v106.11.2125.2125

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání